HH

Harry H. Stine

North America, Iowa, United States, Adel

Description

Harry Stine is synonymous with many titles – innovator, businessman, entrepreneur – but the title holding the most significance to him is fa...

Investor Profile

Harry H. Stine has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Harry H. Stine frequently co-invest with?

Mayo Clinic
North America, Minnesota, United States, Rochester
Co-Investments: 1
Mirae Asset
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Southeast Minnesota Capital Fund
North America, Minnesota, United States, Rochester
Co-Investments: 1
Regeneron
North America, New York, United States, Tarrytown
Co-Investments: 1

What are some of recent deals done by Harry H. Stine?

Vyriad

Rochester, Minnesota, United States

Vyriad is a clinical stage biopharmaceutical company.

Biotechnology
Series BDec 23, 2025
Amount Raised: $25,000,000
Vyriad

Rochester, Minnesota, United States

Vyriad is a clinical stage biopharmaceutical company.

Biotechnology
Series BMay 17, 2022
Amount Raised: $29,500,000

Find More Investors Like Harry H. Stine

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Harry H. Stine | Pipeseed